Advertisement

Study of the mechanism underlying hsa-miR338-3p downregulation to promote fibrosis of the synovial tissue in osteoarthritis patients

  • Changzhi Song
  • Xiaozu XuEmail author
  • Ya Wu
  • Biao Ji
  • Xiaoye Zhou
  • Ling Qin
Original Article
  • 28 Downloads

Abstract

Osteoarthritis (OA) is a degenerative joint disease characterized by the degradation of joint cartilage, the formation of osteophyma at joint margins, and synovial changes. Whereas lesions of the joint cartilage were the key point of the research and treatment of osteoarthritis before, a recent study showed that the synovium plays a crucial role in the pathological progress of OA. The inflammatory environment in the joints of OA patients always results in the overactivation of fibroblast-like synoviocytes (FLSs), which produce a multitude of inflammatory factors and media, not only leading to the degradation and injury of the cartilage tissue and promoting the development of osteoarthritis but also resulting in synovial fibrosis and joint stiffness. Therefore, the synovium has attracted increasing attention in the research of OA, and the study of the mechanism of activation of FLSs and the fibrosis of joint synovium may shed new light on OA treatment. By using high-throughput screening, we have identified that hsa-miR338-3p is significantly downregulated in the synovial tissue and joint effusion from OA patients. A functional study showed that overexpression of hsa-miR338-3p in the FLSs inhibited the TGF-β1-induced overactivation of the TGF-β/Smad fibrosis regulation pathway by suppressing TRAP-1 expression and thus reducing the TGF-β1-induced activation of the FLSs and the expression of vimentin and collagen I, two fibrosis markers. Meanwhile, a mechanism study also showed that the upregulation of hsa-miR338-3p reduced Smad2/3 phosphorylation by suppressing TRAP-1 and thus inhibited the TGF-β/Smad pathway and TIMP1, a downstream protein. The present study, for the first time, illustrates the role of hsa-miR338-3p in synovial fibrosis in OA patients and the related mechanism, which is of importance to the treatment of OA and its complications by targeting the FLSs and synovial tissue. Hsa-miR338-3p not only has the potential to be a target for the gene therapy of OA but also has the potential to be a new marker for the diagnosis of clinical progression in OA patients.

Keywords

Osteoarthritis (OA) Synovium Fibrosis Hsa-miR338-3p TRAP-1 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests, and all authors should confirm its accuracy.

References

  1. 1.
    Namazi H, Torabi S (2007) Novel use of botulinum toxin to ameliorate arthrofibrosis: an experimental study in rabbits. Toxicol Pathol 35(5):715–718CrossRefPubMedGoogle Scholar
  2. 2.
    Biggs-Kinzer A, Murphy B, Shelbourne KD, Urch S (2010) Perioperative rehabilitation using a knee extension device and arthroscopic debridement in the treatment of arthrofibrosis. Sports Health 2(5):417–423CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Monument MJ, Hart DA, Befus AD, Salo PT, Zhang M, Hildebrand KA (2010) The mast cell stabilizer ketotifen fumarate lessens contracture severity and myofibroblast hyperplasia: a study of a rabbit model of posttraumatic joint contractures. J Bone Joint Surg Am 92(6):1468–1477CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Fukui N, Tashiro T, Hiraoka H, Oda H, Nakamura K (2000) Adhesion formation can be reduced by the suppression of transforming growth factor-beta1 activity. J Orthop Res 18(2):212–219CrossRefPubMedGoogle Scholar
  5. 5.
    Hildebrand KA1, Zhang M, Salo PT, Hart DA (2008) Joint capsule mast cells and neuropeptides are increased within four weeks of injury and remain elevated in chronic stages of posttraumatic contractures. J Orthop Res 26(10):1313–1319CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Piersma B, Bank RA, Boersema M (2015) Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge. Front Med 2:59CrossRefGoogle Scholar
  7. 7.
    Li Y, Lua I, French SW, Asahina K (2016) Role of TGF-β signaling in differentiation of mesothelial cells to vitamin A-poor hepatic stellate cells in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 310(4):G262–G272CrossRefPubMedGoogle Scholar
  8. 8.
    Asghari MH, Hobbenaghi R, Nazarizadeh A, Mikaili P (2015) Hydro-alcoholic extract of Raphanus sativus L. var niger attenuates bleomycin-induced pulmonary fibrosis via decreasing transforming growth factor β1 level. Res Pharm Sci 10(5):429–435PubMedPubMedCentralGoogle Scholar
  9. 9.
    Hao J, Ju H, Zhao S, Junaid A, Scammell-La Fleur T, Dixon IM (1999) Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J Mol Cell Cardiol 31(3):667–678Google Scholar
  10. 10.
    Kopp J, Preis E, Said H, Hafemann B, Wickert L, Gressner AM, Pallua N, Dooley S (2005) Abrogation of transforming growth factor-beta signaling by Smad7 inhibits collagen gel contraction of human dermal fibroblasts. J Biol Chem 280(22):21570–21576CrossRefPubMedGoogle Scholar
  11. 11.
    Goto Y, Manabe N, Uchio-Yamada K, Yamaguchi-Yamada M, Inoue N, Yamamoto Y, Ogura A, Nagano N, Miyamoto H(2004)Augmented cytoplasmic Smad4 induces acceleration of TGF-beta1 signaling in renal tubulointerstitial cells of hereditary nephrotic ICGN mice with chronic renal fibrosis; possible role for myofibroblastic differentiation. Cell Tissue Res 315 (2): 209–221Google Scholar
  12. 12.
    Karkkainen MJ, Petrova T (2014) Vascular endothelial growth factor re-ceptors in the regulation of angiogenesis and lymphangion genesis. Oncogene 19(49):5598–5605CrossRefGoogle Scholar
  13. 13.
    Makboul R, Refaiy AE, Badary FA, Abdelkawi IF, Merseburger AS, Mohammed RA (2015) Expression of sur-vivin in squamous cell carcinoma and transitional cell carcinoma of the urinary bladder: A comparative immunohistochemical study. Korean J Urol 56(1):31–40CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Im CN, Seo JS (2014) Overexpression of tumor necrosis factor receptor-associated protein 1 (TRAP1), leads to mitochondrial aberrations in mouse fibroblast NIH/3T3 cells. BMB Rep 47(5):280–285CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Amoroso MR, Matassa DS, Agliarulo I, Avolio R, Lu H, Sisinni L, Lettini G, Gabra H, Landriscina M, Esposito F (2016) TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial-mesenchymal transition. Cell Death Dis 7(12):e2522CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Wang X, Chu J, Wen CJ, Fu SB, Qian YL, Wo Y, Wang C, Wang DR (2015) Functional characterization of TRAP1-like protein involved in modulating fibrotic processes mediated by TGF-β/Smad signaling in hypertrophic scar fibroblasts. Exp Cell Res 332(2):202–211CrossRefPubMedGoogle Scholar
  17. 17.
    Wang X, Qian Y, Jin R, Wo Y, Chen J, Wang C, Wang D (2013) Effects of TRAP-1-like protein (TLP) gene on collagen synthesis induced by TGF-β/Smad signaling in human dermal fibroblasts. PLoS ONE 8(2):e55899CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Sun X, Han Y, Liu Y, Tang Y, Wang J (2017) Proliferation and apoptosis of rheumatoid arthritis fibroblast-like synoviocytes following signal transducer and activator of transcription 3 RNA interference delivery. J Cell Biochem.  https://doi.org/10.1002/jcb.26596 CrossRefPubMedGoogle Scholar
  19. 19.
    Xue M, Gong S, Dai J, Chen G, Hu J (2016) The treatment of fibrosis of joint synovium and frozen shoulder by Smad4 gene silencing in rats. PLoS ONE 11(6):e0158093CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Samuels J, Krasnokutsky S, Abramson SB (2008) Osteoarthritis: a tale of three tissues. Bull NYU Hosp Jt Dis 66(3):244–250PubMedGoogle Scholar
  21. 21.
    Roman-Blas JA, Castañeda S, Largo R, Herrero-Beaumont G (2009) Osteoarthritis associated with estrogen deficiency. Arthritis Res Ther 11(5):241CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Jin-yu Zhu, Man Shi, Wei Zhang (2010) Screening of differentially expressed genes associated with synovium in knee osteoarthritis by high density cDNA microarrays. Guo Ji Gu Ke Xue Za Zhi 31(6):384–386Google Scholar
  23. 23.
    Ding XN, Yuan JH, Cheng AP (2010) MRI imaging of the synovium changes in knee joints with degenerative osteoarthrosis. Zhongguo Lin Chuang Yi Xue Ying Xiang Za Zhi 21(1):31–33Google Scholar
  24. 24.
    Bai L, Kong R, Li Y, Wang Y (2009) Immunohistochemical expression and significance of matrix metalloproteinase-7, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-3 in osteoarthritis patients’ synovium of knee joint. Zhongguo Yi Ke Da Xue Xue Bao 38(4):284–285Google Scholar
  25. 25.
    Wu HK, Li RH, Zhong Y (2010) Effects of Fuyuan capsule on expression of IL-1β,MMP-13 and iNOS in synovium in experimental osteoarthritis of rabbits. Chong Qing Yi Ke Da Xue Xue Bao 35(7):1004–1009Google Scholar
  26. 26.
    Sun ZM, Ling M, Liu M, Zhang YG (2009) Expression of interleukin-1 beta and tumor necrosis factor-alpha in the synovium and synovial fluid of patients with Kashin-Beck disease and osteoarthritis. Nan Fang Yi Ke Da Xue Xue Bao 29(1):5–8PubMedGoogle Scholar
  27. 27.
    Guo J, Zhang N, Qijia LI (2008) The correlative study on the expression metalloproteinase-13 and interleukin-6 in ostcoarthritis. J North China Coal Med Univ 10(3):297–299Google Scholar
  28. 28.
    Wang FL, Jiang JM, Xiao J (2010) The expression and significance of interleukin-18 in the synoviocyte of patients with osteoarthritis. Zhonghua Feng Shi Bing Xue Za Zhi 14(4):260–262Google Scholar
  29. 29.
    Chikenji T, Gingery A, Zhao C, Vanhees M, Moriya T, Reisdorf R, An KN, Amadio PC (2014) Transforming growth factor-β (TGF-β) expression is increased in the sub synovial connective tissues of patients with idiopathic carpal tunnel syndrome. J Orthop Res 32(1):116–122CrossRefPubMedGoogle Scholar
  30. 30.
    Yamanaka Y, Gingery A, Oki G, Yang TH, Zhao C, Amadio PC (2018) Blocking fibrotic signaling in fibroblasts from patients with carpal tunnel syndrome. J Cell Physiol 233(3):2067–2074CrossRefPubMedGoogle Scholar
  31. 31.
    Gingery A, Yang TH, Passe SM, An KN, Zhao C, Amadio PC (2014) TGF-β signaling regulates fibrotic expression and activity in carpal tunnel syndrome. J Orthop Res 32(11):1444–1450CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Yu B, Li W, Al F, Chen Z (2017) MicroRNA-33a deficiency inhibits proliferation and fibrosis through inactivation of TGF-β/Smad pathway in human cardiac fibroblasts. Pharmazie 72(8):456–460PubMedGoogle Scholar
  33. 33.
    Xiao J, Meng XM, Huang XR, Chung AC, Feng YL, Hui DS, Yu CM, Sung JJ, Lan HY (2012) miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice. Mol Ther 20(6):1251–1260CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Chung AC, Huang XR, Meng X, Lan HY (2010) miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J Am Soc Nephrol 21(8):1317–1325CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Eulalio A, Huntzinger E, Izaurralde E (2008) Getting to the root of miRNA-mediated gene silencing. Cell 132(1):9–14CrossRefPubMedGoogle Scholar
  36. 36.
    Eulalio A, Huntzinger E, Izaurralde E (2008) GW182 interaction with Argonaute is essential for miRNA-mediated translational repression and mRNA decay. Nat Struct Mol Biol 15(4):346–353CrossRefPubMedGoogle Scholar
  37. 37.
    Felts SJ, Owen BA, Nguyen P, Trepel J, Donner DB, Toft DO (2000) The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties. J Biol Chem 275(5):3305–3312CrossRefPubMedGoogle Scholar
  38. 38.
    Altieri DC (2011) Mitochondrial compartmentalized protein folding and tumor cell survival. Oncotarget 2(4):347–351CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Moreno-Sánchez R, Rodríguez-Enríquez S, Marín-Hernández A, Saavedra E (2007) Energy metabolism in tumor cells. FEBS J 274(6):1393–1418CrossRefPubMedGoogle Scholar
  40. 40.
    Hardy M, Rockenbauer A, Vásquez-Vivar J, Felix C, Lopez M, Srinivasan S, Avadhani N, Tordo P, Kalyanaraman B (2007) Detection, char-acterization, and decay kinetics of ROS and thiyl adducts of mito DEPMPO spin trap. Chem Res Toxicol 20(7):1053–1060CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature B.V. 2018

Authors and Affiliations

  • Changzhi Song
    • 1
  • Xiaozu Xu
    • 1
    Email author
  • Ya Wu
    • 1
  • Biao Ji
    • 1
  • Xiaoye Zhou
    • 2
  • Ling Qin
    • 1
  1. 1.Department of OrthopaedicsYancheng City No. 1 People’s HospitalYanchengChina
  2. 2.Department of Gynecology and ObstetricsYancheng City No. 1 People’s HospitalYanchengChina

Personalised recommendations